FDA Approves First Wearable Device to Monitor Glucose, Ketone Levels (patientcareonline.com)
(Tuesday August 25, 2026 @05:01PM (BeauHD)
from the first-of-its-kind dept.)
- Reference: 0185157054
- News link: https://science.slashdot.org/story/26/08/25/210214/fda-approves-first-wearable-device-to-monitor-glucose-ketone-levels
- Source link: https://www.patientcareonline.com/view/fda-authorizes-first-wearable-device-to-continuously-monitor-glucose-ketones
The FDA has [1]authorized the first wearable in the U.S. to continuously monitor ketone levels and the [2]first device globally to track both ketones and glucose together in a single system . From a report:
> [Abbott's] Libre Duo 10 Day continuously measures both glucose and ketone levels in the fluid just beneath the skin every minute, day and night. Readings are transmitted wirelessly to a compatible smartphone, where users can view current glucose and ketone levels and whether those values are trending up or down. The device also can send automatic alerts if ketone levels reach a concerning threshold. The FDA noted that ketone information should be interpreted in the context of glucose readings and symptoms.
>
> Ketones are produced when the body uses fat instead of glucose for energy. When ketone levels rise too high, patients with diabetes can develop diabetic ketoacidosis (DKA), a serious complication that can progress quickly and become life-threatening without prompt treatment. Until now, patients who needed ketone monitoring had to test separately using methods that provided a single measurement at one point in time. Those tests could not show whether ketone levels were rising or falling. For patients with diabetes -- particularly those at higher risk for DKA -- continuous glucose and ketone monitoring may provide earlier warning of metabolic deterioration and support timelier sick-day management, hydration, insulin adjustment, and escalation of care when clinically appropriate.
[1] https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-wearable-device-continuously-monitors-both-ketone-levels-and-blood-sugar
[2] https://www.patientcareonline.com/view/fda-authorizes-first-wearable-device-to-continuously-monitor-glucose-ketones
> [Abbott's] Libre Duo 10 Day continuously measures both glucose and ketone levels in the fluid just beneath the skin every minute, day and night. Readings are transmitted wirelessly to a compatible smartphone, where users can view current glucose and ketone levels and whether those values are trending up or down. The device also can send automatic alerts if ketone levels reach a concerning threshold. The FDA noted that ketone information should be interpreted in the context of glucose readings and symptoms.
>
> Ketones are produced when the body uses fat instead of glucose for energy. When ketone levels rise too high, patients with diabetes can develop diabetic ketoacidosis (DKA), a serious complication that can progress quickly and become life-threatening without prompt treatment. Until now, patients who needed ketone monitoring had to test separately using methods that provided a single measurement at one point in time. Those tests could not show whether ketone levels were rising or falling. For patients with diabetes -- particularly those at higher risk for DKA -- continuous glucose and ketone monitoring may provide earlier warning of metabolic deterioration and support timelier sick-day management, hydration, insulin adjustment, and escalation of care when clinically appropriate.
[1] https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-wearable-device-continuously-monitors-both-ketone-levels-and-blood-sugar
[2] https://www.patientcareonline.com/view/fda-authorizes-first-wearable-device-to-continuously-monitor-glucose-ketones
Glucose-Ketone Index (GKI) tracking for dietary co (Score:2)
by sonamchauhan ( 587356 )
Dr Thomas Seyfried's work on dietary approaches to treating cancer uses Glucose-Ketone Index (GKI) -- a simple way to track how effectively you're shifting away from glucose metabolism toward ketone metabolism. The cancer patient makes dietary decisions to drive their GKI numerical value in the low single digits.
GKI Calculation:
GKI = Blood glucose à Blood ketones
Target Ranges:
General cancer management: GKI 2-3
Active treatment: GKI 1-2
Advanced/aggressive cancers: GKI below 1 (temporarily, with medical s
Fatkins (Score:2)
Speaking as someone who lost 80 lb and kept it off using Atkins for the reduction... This would be great for that, no guessing.
Re: (Score:1)
That's a serious reduction in weight, well done.